Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?

Autor: Ouvrard E; Nuclear Medicine and Molecular Imaging, Institut de Cancérologie Strasbourg Europe (ICANS), University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France., Kaseb A; Nuclear Medicine and Molecular Imaging, Institut de Cancérologie Strasbourg Europe (ICANS), University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France.; Radiology, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia., Poterszman N; Nuclear Medicine and Molecular Imaging, Institut de Cancérologie Strasbourg Europe (ICANS), University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France., Porot C; Radiopharmacy, Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France., Somme F; Nuclear Medicine and Molecular Imaging, Institut de Cancérologie Strasbourg Europe (ICANS), University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France., Imperiale A; Nuclear Medicine and Molecular Imaging, Institut de Cancérologie Strasbourg Europe (ICANS), University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France.; IPHC, UMR 7178, CNRS/Unistra, Strasbourg, France.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2024 Jan 15; Vol. 10, pp. 1320574. Date of Electronic Publication: 2024 Jan 15 (Print Publication: 2023).

177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT.

Autor: Mazzara C; Radiophysics, Institut de Cancérologie de Strasbourg Europe (ICANS), 17 rue Albert Calmette, 67093, Strasbourg, France. c.mazzara@icans.eu., Salvadori J; Radiophysics, Institut de Cancérologie de Strasbourg Europe (ICANS), 17 rue Albert Calmette, 67093, Strasbourg, France. j.salvadori@icans.eu.; Nuclear Medicine and Molecular Imaging, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France. j.salvadori@icans.eu., Ritzenthaler F; Radiophysics, Institut de Cancérologie de Strasbourg Europe (ICANS), 17 rue Albert Calmette, 67093, Strasbourg, France.; Nuclear Medicine and Molecular Imaging, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France., Martin S; Radiophysics, Institut de Cancérologie de Strasbourg Europe (ICANS), 17 rue Albert Calmette, 67093, Strasbourg, France.; Nuclear Medicine and Molecular Imaging, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France., Porot C; Radiopharmacy, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France., Imperiale A; Nuclear Medicine and Molecular Imaging, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France.; Faculty of Medicine, FMTS, University of Strasbourg, Strasbourg, France.; Molecular Imaging - DRHIM, IPHC, UMR 7178, CNRS/University of Strasbourg, Strasbourg, France.

Publikováno v: EJNMMI physics [EJNMMI Phys] 2022 May 03; Vol. 9 (1), pp. 33. Date of Electronic Publication: 2022 May 03.

Partial volume correction for Lu-177-PSMA SPECT.

Autor: Liu, Yibin¹ (AUTHOR), Lu, Zhonglin^1,2 (AUTHOR), Chen, Gefei¹ (AUTHOR), Shi, Kuangyu³ (AUTHOR) kuangyu.shi@dbmr.unibe.ch, Mok, Greta S. P.^1,2 (AUTHOR) gretamok@um.edu.mo

Publikováno v: EJNMMI Physics. 11/12/2024, Vol. 11 Issue 1, p1-15. 15p.

Place des consultations radiopharmaceutiques dans la prise en charge de l’hyperthyroïdie en médecine nucléaire

Autor: Hammer, C., Keita Camara, F., Porot, C., Schneegans, O., Bourahla, K., Coliat, P., Prebay, D.

Publikováno v: In Médecine Nucléaire March-April 2019 43(2):199-200

Hématopoïèse extramédullaire intrathoracique : intérêt de l’imagerie hybride

Autor: Moulin, V., Ungureanu, C., Ojeda-Uribe, M., Thiebault, S., Porot, C., Angoue, O., Boulahdour, H.

Publikováno v: In Journal de Radiologie diagnostique et interventionnelle November 2012 93(11):948-953